Table 1.
Clinical features | Family 1 |
Family 2 |
Family 3 |
||
---|---|---|---|---|---|
II-1 | II-2 | II-1 | II-1 | II-2 | |
Origin | Spanish | Turkish | Greek | ||
Consanguinity | No | Yes | No | ||
Clinical diagnosis | Axonal CMT | Axonal CMT | Axonal CMT | Axonal CMT | |
Age at onset (y) | 1.25 | 1.25 | 10 | 10 | 10 |
Age at last examination (y) | 52 | 44 | 19 | 19 | 17 |
Initial symptoms | Late walking | Distal muscle weakness | Unsteady gait, ataxia | Unsteady gait, frequent falls | |
Main symptoms | Severe distal LL weakness and atrophy, foot deformities | Distal muscle weakness | Severe LL weakness, ataxia | Distal LL weakness | |
Disease course | Minimal progression | Minimal progression | Minimal progression | Minimal progression | Minimal progression |
Gait | Steppage | Steppage | Steppage | Steppage, need bilateral assistance, ankle foot orthoses | Steppage |
Muscle weakness (MRC) | |||||
UL proximal | 5 | 5 | 5 | 5 | 5 |
UL distal | 5 | 0-3 | 4 | 4 | 5- |
LL proximal | 5 | 5 | 5 | 4 | 5 |
LL distal | 0 | 0 | Dorsiflexion: 0, plantar flexion: 2 | 0 | Dorsiflexion: 0, plantar flexion: 3 |
Muscle wasting | Severe dLL, minimal dUL | Severe dLL, dUL | dLL | dLL, minimal dUL | dLL |
Tendon reflexes | Achilles: 0, other: 3 | Achilles: 0, other: 1 | Achilles: 0, knee: 1, other: 2 | Achilles: 0, knee: 1, UL: 3 | Achilles: 0, other: 2 |
Skeletal deformities | Pes cavus | Pes cavus | Pes cavus | Pes cavus | |
Sensory loss | |||||
Light touch | LL | LL | dLL | LL | No |
Pain/temperature | LL | LL | dLL | LL | dLL |
Proprioception | No | No | No | LL | No |
Vibration | LL, dUL | LL, dUL | No | LL, dUL | dLL |
Nystagmus | Yes | Yes | Yes | Yes | Yes |
Involuntary movements | None | None | None | Tremor, chorea, athetosis | Chorea, myoclonus, left UL dystonia |
Brain MRI | Normal | Normal | Normal | “Eye-of-the-tiger” sign in basal ganglia | Unknown |
Biochemical assays | |||||
Serum lactateh | 2.5 mmol/La | 1.9 mmol/Lb | 1.03 mmol/Lc | 2.02 mmol/Ld | NA |
Serum pyruvatei | 84 μmol/Le | 85 μmol/Lf | NA | 120 μmol/Lg | NA |
Lactate/pyruvatej | 29.8 | 22.4 | NA | 16.83 | NA |
Additional features | NA | NA | Intellectual disability | NA | Rolandic epilepsy |
Abnormal values are highlighted in bold. Muscle weakness scale (MRC): 0 = no contraction, 1 = flicker or trace of contraction, 2 = active movement, with gravity eliminated, 3 = active movement against gravity, 4 = active movement against gravity and resistance, 5 = normal power. Tendon reflexes scale: 0 = absent, 1 = reduced, 2 = normal, 3 = increased, 4 = clonus.
CMT, Charcot-Marie-Tooth disease; dLL, distal lower limb; dUL, distal upper limb; LL, lower limb; UL, upper limb.
22.52 mg/dL.
17.12 mg/dL.
9.28 mg/dL.
18.20 mg/dL.
0.74 mg/dL.
0.75 mg/dL.
1.06 mg/dL.
Reference range 0.5-2.2 mmol/L (4.5-19.82 mg/dL).
Reference range 40-130 μmol/L (0.35-1.14 mg/dL).
Reference value <25.